Systemic delivery of NSC697923, small molecule inhibitor of UBE2N, significantly decreased melanoma xenograft growth. »
09/12/18

High plasma VEGF-A levels (>5.1 pg/mL) observed with shorter PFS. »
09/12/18

Both treatment strategies produce equivalent and better than expected outcomes. »
02/20/18

KX2-361 binds directly to tubulin and disrupts microtubule architecture in glioma cells. »
05/15/18

Data confirm and expand previous studies of high frequency of germline mutations. »
09/26/18

Antineoplastic effect of I2 accompanied by diminished expression of stemness markers. »
09/26/18

Household size consistently significant predictor of all cancer incidence variables. »
09/26/18

Feasibility of WBV during intensive/high-dose chemotherapy of hospitalized cancer patients. »
09/25/18

Significantly higher amounts of DSBs detected in IGROV1 cells after combination. »
09/25/18

Tool to identify anticancer drugs targeting acid-adapted cancer cells. »
09/25/18